Comparison of the toxicity profiles of ISIS 1082 and ISIS 2105, phosphorothioate oligonucleotides, following subacute intradermal administration in Sprague-Dawley ratsHENRY, S. P; GRILLONE, L. R; ORR, J. L et al.Toxicology (Amsterdam). 1997, Vol 116, Num 1-3, pp 77-88, issn 0300-483XArticle

In vitro toxicological evaluation of ISIS 1082, a phosphorothioate oligonucleotide inhibitor of herpes simplex virusCROOKE, R. M; HOKE, G. D; SHOEMAKER, J. E. E et al.Antimicrobial agents and chemotherapy. 1992, Vol 36, Num 3, pp 527-532, issn 0066-4804Article

Effect of antisense oligonucleotides on cytokine release from human keratinocytes in an in vitro model of skinCROOKE, R. M; CROOKE, S. T; GRAHAM, M. J et al.Toxicology and applied pharmacology. 1996, Vol 140, Num 1, pp 85-93, issn 0041-008XArticle

Toxicological and pharmacokinetic properties of chemically modified antisense oligonucleotide inhibitors of PKC-α and C-raf kinaseHENRY, S. P; MONTEITH, D; BENNETT, F et al.Anti-cancer drug design. 1997, Vol 12, Num 5, pp 409-420, issn 0266-9536Article